.
- Are you looking for professional accounting services?
- Phone: +0047 93982173 XNUMX
- Service in Polish
- Discounts for new customers
- Topnor www.topnor.no
Health Minister Bent Høie (H) says that the vaccination strategy in Norway may change and that it depends on how safe we arrange the delivery of these vaccines.
In total, about 88 doses of vaccines have reached Norway, but only 000 have been used so far.
By comparison, in Denmark, 52 were vaccinated with the first dose.
Health Minister Bent Høie explains that the reason for this is time as it takes time to distribute the product to all municipalities in the country.
At the same time, the government has so far decided to withhold half of the doses.
- The vaccine needs to be given in two doses, and for Norway it would be inappropriate to use all doses of the vaccine in the first phase and live with the uncertainty of whether we have enough doses for the second phase of vaccination, says Høie for.
Uncertainty before Christmas
Høie explains that before Christmas, when the vaccination strategy was being developed in Norway, there was uncertainty about the timing of the delivery of new vaccine deliveries.
- Before Christmas, delivery dates were changed from hour to hour. Then we decided that using all the doses at once was too high a risk. We can change that soon if the delivery is safer, he says.
Vaccinations in Norway
One of those who responded to the slow vaccination is Raymond Johansen of the Labor Party.
- It does not work! At worst, people can die, says upset Raymond Johansen, adding:
- Why do we not prioritize nursing homes so far? I get calls every day from elderly people who are despairing because it takes too long. It prevails among the elderly in Norway tremendous anxiety. Also among those who do not live in nursing homes. The current pace is simply unacceptable, says Johansen.
Experts believe the government's strategy makes sense.
- The logistics needed to ship vaccines to all municipalities cannot be underestimated. I think what Norway has done with the vaccine is looking good, says Gunnveig Grødeland, a vaccine researcher at the University of Oslo.
We can change the strategy - No rush
Ørjan Olsvik, professor of medical microbiology at the University of Tromsø, also agrees.
